Newsroom

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

BANGALORE, Inde--(BUSINESS WIRE)--TVS Motor Company, filiale de TVS VENU et l’un des principaux constructeurs mondiaux de deux et trois-roues, a annoncé aujourd’hui la nomination de Peyman Kargar au poste d’administrateur et de directeur général, à compter du 27 janvier 2027. Peyman succédera à K. N. Radhakrishnan, qui conservera ses fonctions jusqu’à cette date afin d’assurer une transition en douceur. À l’issue de cette transition, M. Radhakrishnan occupera le poste d’administrateur non exécu...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 27.08.2026 FEX.LN IE00B8X9NW27 1,388,395.00 USD 160,937,579.93  115.916  ...

ALEXANDRIA, Va.--(BUSINESS WIRE)--Alan B. Johnson has been selected to receive the prestigious 2026 American Inns of Court Professionalism Award for the Tenth Circuit. Johnson is a judge on the U.S. District Court for the District of Wyoming. He will receive the award at a special awards ceremony in Colorado Springs, Colorado, in September. “Judge Alan B. Johnson’s storied career… include[s] more than 40 years as an active U.S. district court judge for the District of Wyoming,” writes Julie Hil...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

NEW YORK--(BUSINESS WIRE)--Bilt, the membership that connects where you live with the places you love, today announced a collaboration with Global Citizen, and Global Citizen Ambassador Hugh Jackman as the featured guest for September Rent Day®. Hugh joins Bilt's monthly Rent Free™ game show, where the better he does, the more Bilt Members win free rent. A two-time Tony winner and an Emmy and Grammy winner, Global Citizen Ambassador Hugh Jackman is hosting the Global Citizen Festival on Central...

NORTH BETHESDA, Md.--(BUSINESS WIRE)--Pinion Immunotherapeutics has published preclinical data supporting ARV-2001, its lead RNA immunotherapy, in the peer-reviewed journal Vaccines. With an Investigational New Drug application cleared by the FDA, Pinion is ready to begin clinical development for women with HPV-16-positive high-grade cervical precancer (CIN2/3). ARV-2001 is designed to clear precancerous lesions without surgery while preserving the cervix and addressing the underlying HPV infec...